SingHealth Institutions will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Community Care

We care for our community and are taking an integrated and life course approach to journey with each of our assigned residents towards a Healthier SG.

Synonym(s):

Let us help!

No matter who you are and what support that you may require in the community, we are here to help you find the information and link up to the resources that you are looking for. Simply tell us who you are and what you are looking for by selecting the options below.

I'm a
Select an option Let us help!
  • Community Partner
  • General Practitioner
  • Resident
and I want to
Select an option
Community Health Services
  • About HealthUP! TM
  • Programme Benefits
  • Events and Activities
  • Useful Resources
  • Frequently Asked Questions
  • About Our Partners
  • Supporting Healthier SG 
  • Health Screening
  • Gestational Diabetes Screening
  • Frailty Screening
  • Functional Screening
  • Community Health Screening Dates
#

What We Do

Community & Population Health

Learn More

Recent News

Awards Inspirational Patient & Caregiver Awards Healthcare professionals come in contact with patients and caregivers every day. Many of them demonstrate extraordinary strength, courage, and resilience in the face of healthcare challenges, which inspire and motivate us in our work and lives. Since 2010, the annual Singapore Health Inspirational Patient & Caregiver Awards (IPCA) celebrate the best of patients, caregivers, and partners who have not only touched our hearts with their exemplary show of strength, courage, and resilinece, but also motivated and partnered with us in our mission to deliver better patient care.
12 May 2026 Read Story
Research New therapy shows promise in treating advanced HER2 mutated lung cancer A global, multicentre, phase 1/2 clinical trial that included clinician-scientists and researchers from MD Anderson Cancer Centre, Seoul National University and the National Cancer Centre Singapore has indicated positive results in treating advanced HER2-mutant non-small-cell lung cancer (NSCLC) with sevabertinib, an oral HER2-targeted tyrosine kinase inhibitor.
21 Oct 2025 Read Story
Upcoming Events